Atrasentan for hormone refractory prostate cancer
Status
|
Suspended
|
Process |
STA pre-2018
|
Referral date |
01 June 2004 |
Topic area
|
|
Provisional Schedule
Closing date for invited submissions / evidence submission: |
TBC |
1st appraisal committee meeting: |
TBC |
2nd appraisal committee meeting |
TBC |
Project Team
Assessment Group / Evidence Review Group: |
TBC |
Communications manager: |
TBC |
Executive Lead: |
TBC |
Project manager: |
TBC |
Technical Lead: |
TBC |
Date
|
Update
|
27 May 2005
|
Topic summary published |
25 August 2006
|
This topic was transferred to the Single technology appraisal (STA) process as part of the Institute's 12th wave work programme. |
8 January 2007
|
Topic is suspended as the manufacturer has not applied for EMEA regulatory approval at this time |
For further information on how we develop guidance, please see our page about NICE technology appraisal guidance